Lexicon Pharmaceuticals Inc. logo

Lexicon Pharmaceuticals Inc.

LXRX | NASDAQ
Chart Builder DCF Calculator
$2.08
+$0.04 (+1.96%)
Sep 22, 2026, 11:27 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-50.34M -200.4M -177.12M -101.94M -87.76M -58.57M
Depreciation & Amortization
621K 534K 554K 427K 292K 2.93M
Stock-Based Compensation
12.52M 13.5M 14.34M 11.52M 10.58M 13.27M
Other Working Capital
2.29M 1.75M -2.43M 340K 3.55M -1.52M
Other Non-Cash Items
-3.75M -6.65M -2.33M 744K 54K -131.57M
Deferred Income Tax
n/a n/a n/a n/a 49K -110K
Change in Working Capital
-26.89M 14.24M 2.66M 402K -10.23M 31.08M
Operating Cash Flow
-67.85M -178.78M -161.9M -88.85M -87.02M -142.97M
Capital Expenditures
n/a -1.03M -470K -1.33M -1.22M -87K
Cash Acquisitions
n/a n/a n/a 69.75M -3.33M 11.01M
Purchase of Investments
-143.55M -338.05M -223.34M -133.95M -34.26M -58.56M
Sales Maturities Of Investments
252.86M 314.4M 173.87M 64.2M 37.59M 268M
Other Investing Acitivies
3.71M 9.31M n/a -69.75M 3.33M 160.39M
Investing Cash Flow
113.02M -15.38M -49.94M -71.08M 2.11M 380.76M
Debt Repayment
-48M n/a 49.96M 48.87M -11.7M -216.58M
Common Stock Repurchased
n/a -1.73M -824K -864K -2.68M -1.03M
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-572K -1.24M n/a 94.21M n/a 69.97M
Financial Cash Flow
-48.5M 238.35M 187.96M 142.21M 22.71M -147.64M
Net Cash Flow
-3.33M 44.19M -23.88M -17.72M -62.2M 90.15M
Free Cash Flow
-67.85M -179.81M -162.37M -90.18M -88.24M -143.06M
Adj. Free Cash Flow
-80.37M -193.31M -176.71M -101.7M -98.82M -156.33M
Maintenance CapEx
n/a n/a -326.95K -1.33M -1.22M -87K
Growth CapEx
n/a -1.03M -143.05K n/a n/a n/a
Owner Earnings
-67.85M -178.78M -162.22M -90.18M -88.24M -143.06M

© 2026 bestshares.com. All rights reserved.